Krystal Biotech is trading at $313.54, down 5.19% in after-hours trading amid broader market weakness; no clear company-specific announcement was identified for October 14.
- U.S. stocks fell after September CPI came in at 3.7%, above the 3.6% forecast, reviving concerns about higher interest rates and weighing on technology shares.
- The regular-session close was $330.69 on October 14. After-hours volume or activity details were not provided.